chr4-127957589-T-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001371590.2(MFSD8):​c.-70A>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00164 in 1,606,132 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0087 ( 23 hom., cov: 32)
Exomes 𝑓: 0.00089 ( 16 hom. )

Consequence

MFSD8
NM_001371590.2 5_prime_UTR_premature_start_codon_gain

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.275

Publications

6 publications found
Variant links:
Genes affected
MFSD8 (HGNC:28486): (major facilitator superfamily domain containing 8) This gene encodes a ubiquitous integral membrane protein that contains a transporter domain and a major facilitator superfamily (MFS) domain. Other members of the major facilitator superfamily transport small solutes through chemiosmotic ion gradients. The substrate transported by this protein is unknown. The protein likely localizes to lysosomal membranes. Mutations in this gene are correlated with a variant form of late infantile-onset neuronal ceroid lipofuscinoses (vLINCL). [provided by RefSeq, Oct 2008]
MFSD8 Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 7
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • macular dystrophy with central cone involvement
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062261224).
BP6
Variant 4-127957589-T-A is Benign according to our data. Variant chr4-127957589-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 129611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00875 (1332/152278) while in subpopulation AFR AF = 0.03 (1247/41564). AF 95% confidence interval is 0.0286. There are 23 homozygotes in GnomAd4. There are 627 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001371590.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MFSD8
NM_001371596.2
MANE Select
c.66A>Tp.Glu22Asp
missense
Exon 2 of 12NP_001358525.1Q8NHS3-1
MFSD8
NM_001371590.2
c.-70A>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 12NP_001358519.1A0A286YF45
MFSD8
NM_001371595.1
c.-70A>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 11NP_001358524.1E7ERQ4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MFSD8
ENST00000641686.2
MANE Select
c.66A>Tp.Glu22Asp
missense
Exon 2 of 12ENSP00000493218.2Q8NHS3-1
MFSD8
ENST00000296468.8
TSL:1
c.66A>Tp.Glu22Asp
missense
Exon 3 of 13ENSP00000296468.3Q8NHS3-1
MFSD8
ENST00000641178.1
c.-70A>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 12ENSP00000492989.1A0A286YF45

Frequencies

GnomAD3 genomes
AF:
0.00869
AC:
1322
AN:
152160
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0298
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00224
AC:
560
AN:
249756
AF XY:
0.00175
show subpopulations
Gnomad AFR exome
AF:
0.0302
Gnomad AMR exome
AF:
0.00131
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.00148
GnomAD4 exome
AF:
0.000894
AC:
1300
AN:
1453854
Hom.:
16
Cov.:
27
AF XY:
0.000783
AC XY:
567
AN XY:
723830
show subpopulations
African (AFR)
AF:
0.0301
AC:
1002
AN:
33244
American (AMR)
AF:
0.00137
AC:
61
AN:
44520
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26006
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39482
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
85672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53386
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5740
European-Non Finnish (NFE)
AF:
0.0000859
AC:
95
AN:
1105690
Other (OTH)
AF:
0.00205
AC:
123
AN:
60114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
50
100
151
201
251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00875
AC:
1332
AN:
152278
Hom.:
23
Cov.:
32
AF XY:
0.00842
AC XY:
627
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0300
AC:
1247
AN:
41564
American (AMR)
AF:
0.00379
AC:
58
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10614
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68002
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
61
122
184
245
306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000691
Hom.:
0
Bravo
AF:
0.00969
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0238
AC:
105
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00265
AC:
322
Asia WGS
AF:
0.00261
AC:
9
AN:
3464
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Neuronal ceroid lipofuscinosis 7 (2)
-
-
2
not provided (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Late-infantile neuronal ceroid lipofuscinosis (1)
-
-
1
Neuronal ceroid lipofuscinosis 7;C4015371:Macular dystrophy with central cone involvement (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
13
DANN
Uncertain
0.98
DEOGEN2
Benign
0.024
T
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.35
N
LIST_S2
Uncertain
0.87
D
MetaRNN
Benign
0.0062
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.97
L
PhyloP100
0.28
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.050
N
REVEL
Benign
0.17
Sift
Benign
0.46
T
Sift4G
Benign
0.62
T
Polyphen
0.0030
B
Vest4
0.15
MutPred
0.26
Gain of glycosylation at S20 (P = 0.021)
MVP
0.70
MPC
0.085
ClinPred
0.0072
T
GERP RS
0.94
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.026
gMVP
0.40
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145529594; hg19: chr4-128878744; COSMIC: COSV107364953; API